{"id":9600,"date":"2010-02-26T18:57:00","date_gmt":"2010-02-26T17:57:00","guid":{"rendered":"http:\/\/bontrade.org\/blog49\/9600\/research-and-markets-eli-lilly-pipeline-products-performance-and-potential-2010-lillys-top-selling-product-is-zyprexa-had-sales-in-2008-of-over-us4-6-billion-business-wire\/"},"modified":"2010-02-26T18:57:00","modified_gmt":"2010-02-26T17:57:00","slug":"research-and-markets-eli-lilly-pipeline-products-performance-and-potential-2010-lillys-top-selling-product-is-zyprexa-had-sales-in-2008-of-over-us4-6-billion-business-wire","status":"publish","type":"post","link":"https:\/\/bontrade.org\/blog49\/9600\/research-and-markets-eli-lilly-pipeline-products-performance-and-potential-2010-lillys-top-selling-product-is-zyprexa-had-sales-in-2008-of-over-us4-6-billion-business-wire\/","title":{"rendered":"Research and Markets: Eli Lilly: Pipeline, Products, Performance and Potential 2010 - Lilly's Top Selling Product Is Zyprexa Had Sales in 2008 of Over US$4.6 Billion (Business Wire)"},"content":{"rendered":"<p>DUBLIN----Research and Markets has announced the addition of the \"Eli Lilly: Pipeline, Products, Performance and Potential\" company profile to their offering.<\/p>\n<p>More:\u00a0<br \/>\n<a target=\"_blank\" href=\"http:\/\/us.rd.yahoo.com\/finance\/news\/rss\/story\/*http:\/\/finance.yahoo.com\/news\/Research-and-Markets-Eli-bw-2801351555.html?x=0\" title=\"Research and Markets: Eli Lilly: Pipeline, Products, Performance and Potential 2010 - Lilly's Top Selling Product Is Zyprexa Had Sales in 2008 of Over US$4.6 Billion (Business Wire)\">Research and Markets: Eli Lilly: Pipeline, Products, Performance and Potential 2010 - Lilly's Top Selling Product Is Zyprexa Had Sales in 2008 of Over US$4.6 Billion (Business Wire)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN----Research and Markets has announced the addition of the \"Eli Lilly: Pipeline, Products, Performance and Potential\" company profile to their offering.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lightning_design_setting":[],"footnotes":""},"categories":[1],"tags":[1179,1177,1176,1178],"class_list":["post-9600","post","type-post","status-publish","format-standard","hentry","category-welcome-start-here-tradecrudeoilchatroom","tag-peter-shork","tag-profit-organizations","tag-trade-crude-live","tag-ym-qm-cl"],"_links":{"self":[{"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/posts\/9600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/comments?post=9600"}],"version-history":[{"count":0,"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/posts\/9600\/revisions"}],"wp:attachment":[{"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/media?parent=9600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/categories?post=9600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bontrade.org\/blog49\/wp-json\/wp\/v2\/tags?post=9600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}